《亞洲股市》菲股跌幅擴至3.2% 台港股跌1.5%-1.6%
中國官方1月製造業PMI升至50.1符預期,非製造業PMI升至54.4遠勝預期。然而,亞太股市今天全面反覆受壓,菲股最傷曾低見6,740,現報6,749,續挫3.2%;越南(VNI)由四個月高位續吐1.2%報1,089;昨天飆升近3.8%的台灣加權指數回吐1.5%收15,265,結束四連升。日經反覆回吐0.4%收27,327。滬指及深成反覆回吐0.4%及0.8%,報3,255及11,997。
港股繼昨天由11個月高位急吐逾600點或2.7%後,今天進一步跌破10天線,午後在科指跌幅曾擴至2.2%低見4,479主導,恆指最多挫401點或1.9%報21,668喘定,現報21,719,續挫350點或1.6%。藍籌股以石藥(01093.HK)、中生(01177.HK)、中升(00881.HK)、新世界(00017.HK)、九倉置業(01997.HK)、舜宇(02382.HK)及恆隆地產(00101.HK)跌幅最大,股價挫逾4%-6%。權重股騰訊(00700.HK)、阿里(09988.HK)、百度(09888.HK)及京東(09618.HK)續跌逾2%-3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.